Search - tctmd.com

Displaying 661 - 680 of 870

Sort: Relevancy | Date

Presentation TCT 2015

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Presenter: Frederick Feit, David J. Maron, Sripal Bangalore

October 15, 2015

Presentation TCT 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh

October 15, 2015

Presentation TCT 2015

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

Presentation TCT 2015

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Presenter: Gerhard C. Schuler, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Presenter: Leo Nelson Hopkins, Tudor G. Jovin

October 14, 2015

Presentation TCT 2015

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Presentation TCT 2015

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Deepak L. Bhatt

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Presenter: William A. Gray, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Pascal Vranckx, Renato D. Lopes

October 14, 2015

Presentation TCT 2015

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Presenter: Pascal Vranckx, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Reversal Agents for Factor Xa Inhibitors

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel

October 14, 2015

Presentation TCT 2015

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

Presenter: Lisa K. Jennings, Matthew T. Roe, Pascal Vranckx

October 14, 2015

Presentation TCT 2015

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

Presenter: John P. Cheatham, Carlos Pedra, Maria Del Trigo

October 13, 2015

Presentation TCT 2015

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

Presenter: Eric A. Cohen, Truls Råmunddal, Ching-Chang Huang

October 13, 2015

Advertisement

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Reversal Agents for Factor Xa Inhibitors

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content